On the Way to Accounting for Lung Modulation Effects in Particle Therapy of Lung Cancer Patients—A Review.

Simple Summary: This research aims to improve the precision of particle therapy for lung cancer treatment. The heterogeneous, microscopic structure of lung tissue leads to a broadening of the very sharp dose profiles of protons and other light ions. This can result in higher doses in healthy tissue as well as a reduced dose in the target volume and thereby reducing the potential benefit of particle therapy for lung cancer. This review summarizes existing models that account for these lung tissue effects and explore how they can be better integrated into treatment planning. By taking into account these so called lung modulation effects, it is possible to target tumors more precisely while minimizing harm to surrounding healthy tissues, ultimately benefiting cancer patients. Particle therapy presents a promising alternative to conventional photon therapy for treating non-small cell lung cancer (NSCLC). However, the heterogeneous structure of lung tissue leads to the degradation of the Bragg peak and thereby to the degradation of the dose distribution. This review offers a comprehensive overview of the models developed to account for these modulation effects. It summarizes studies focused on determining modulation power as a predictor of this so-called lung modulation. In addition, the review covers early investigations on dose uncertainties caused by lung modulation in CT-based lung phantoms and patient anatomies and discusses future challenges in integrating these solutions into clinical treatment planning routines. [ABSTRACT FROM AUTHOR]